The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.The reported patient effect of dissection is listed in the xience prime everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined; however, the subsequent treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design, or labeling of the device.
|
It was reported that the procedure was to treat a moderately tortuous, heavily calcified left circumflex left circumflex artery.Post stent implantation of a 2.5x12mm xience prime stent, a dissection was noted.Another 2.5x15mm xience prime stent was used to treat the dissection.There was no adverse patient sequela and no clinically significant delay.No additional information was provided.
|